Prophylaxis for Yersinia pestis Exposure
Bold recommendation: Give 7 days of single‑agent oral prophylaxis with a first‑line fluoroquinolone (ciprofloxacin or levofloxacin) or doxycycline, started as soon as possible after qualifying exposure; stop pre‑exposure prophylaxis 48 hours after last perceived exposure. 1
Who should receive post‑exposure prophylaxis (PEP)
- Close (<6 feet), sustained, unprotected contact with a pneumonic plague patient; certain lab accidents; direct/close contact with infected animals (e.g., veterinary exposure). 1
Regimens (choose ONE agent; do not combine for prophylaxis)
Adults (≥18 years) first‑line:
- Ciprofloxacin 500–750 mg PO every 12 h, or
- Levofloxacin 500–750 mg PO every 24 h, or
- Moxifloxacin 400 mg PO every 24 h, or
- Doxycycline 100 mg PO every 12 h. 1
Children (≥1 month to ≤17 years) first‑line:
- Ciprofloxacin 15 mg/kg PO every 12 h (max 750 mg/dose), or
- Levofloxacin: <50 kg: 8 mg/kg PO every 12 h (max 250 mg/dose); ≥50 kg: 500–750 mg PO every 24 h, or
- Doxycycline: <45 kg: 2.2 mg/kg PO every 12 h; ≥45 kg: 100 mg PO every 12 h. 1
Pregnancy (PEP mirrors nonpregnant, but prefer fluoroquinolones):
- First‑line: Ciprofloxacin 500 mg PO every 8 h or 750 mg PO every 12 h; Levofloxacin 750 mg PO every 24 h.
- Alternatives: Moxifloxacin 400 mg PO every 24 h; Ofloxacin 400 mg PO every 12 h; Doxycycline 100 mg PO every 12 h; TMP‑SMX 5 mg/kg (TMP) PO every 12 h. [1–1]
Duration:
- Post‑exposure prophylaxis: 7 days.
- Pre‑exposure prophylaxis (for ongoing high‑risk operations): discontinue 48 hours after last perceived exposure. 1
Alternatives if first‑line not available/tolerated (adults/children): Ofloxacin, gemifloxacin (adults), tetracycline, minocycline, omadacycline (adults), trimethoprim‑sulfamethoxazole (weight‑based). Use when appropriate to patient age and contraindications. 1
Rationale prioritizing morbidity, mortality, and QOL
- CDC 2021 MMWR guidelines (most recent, high‑quality) recommend single‑agent oral prophylaxis to prevent rapidly fatal pneumonic plague; timing and adherence directly impact mortality prevention. 1
- Experimental data favor fluoroquinolones over doxycycline for inhalational exposures; ciprofloxacin PEP showed superior protection in animal models, supporting choice when feasible. 2, 3
Implementation steps
- Confirm qualifying exposure and start PEP immediately; do not wait for symptoms. 1
- Select first‑line agent above; adjust for age, pregnancy, QT risk (moxifloxacin), dental risks with tetracyclines in young children, and sulfonamide cautions in early pregnancy. 1
- Educate on strict 7‑day adherence; monitor for fever, cough, dyspnea—if symptoms develop, switch to full treatment (not prophylaxis) and isolate for suspected pneumonic plague. 1
- Use PPE and patient isolation; prophylaxis does not replace protective measures. 1
- If engineered resistance suspected (bioterrorism), target agent selection to susceptibility data as they become available. 1
Common pitfalls and how to avoid them
- Delayed start of PEP after high‑risk exposure → start immediately to reduce mortality. 1
- Using dual antibiotics for prophylaxis → monotherapy only; reserve dual therapy for treatment. 1
- Stopping too soon → complete 7 days for PEP; for pre‑exposure use, stop 48 h after last exposure. 1
- Inappropriate pediatric tetracycline use (<8 years) when safer options exist → prefer fluoroquinolones or TMP‑SMX when indicated. 1
- Ignoring QT risk with moxifloxacin or using ciprofloxacin via feeding tubes (not recommended) → choose alternative agents/routes accordingly. 1
Notes on evidence strength and nuances
- 2021 CDC MMWR guidelines are the most recent, comprehensive, and authoritative source guiding prophylaxis. [1–1]
- Animal data suggest ciprofloxacin superiority over doxycycline for aerosolized exposure; nonetheless, guidelines list both as first‑line, enabling practical, life‑saving options when availability varies. 2, 3, 1